Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery.

Meyer, Axel H; Feldsien, Thomas M; Mezler, Mario; Untucht, Christopher; Venugopalan, Ramakrishna; Lefebvre, Didier R

Meyer, Axel H; Feldsien, Thomas M; Mezler, Mario; Untucht, Christopher; Venugopalan, Ramakrishna; Lefebvre, Didier R.

Afiliação

Meyer AH; Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany.
Feldsien TM; Drug Delivery and Combination Products, Development Sciences, AbbVie Inc., 1 N Waukegan Road, North Chicago, IL 60064, USA.
Mezler M; Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany.
Untucht C; Neuroscience Discovery, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany.
Venugopalan R; Drug Delivery and Combination Products, Development Sciences, AbbVie Inc., 1 N Waukegan Road, North Chicago, IL 60064, USA.
Lefebvre DR; Drug Delivery and Combination Products, Development Sciences, AbbVie Inc., 1 N Waukegan Road, North Chicago, IL 60064, USA.

Pharmaceutics ; 15(4)2023 Mar 29.

Article em En | MEDLINE | ID: mdl-37111587

Palavras-chave

blood brain barrier; central nervous system; convection enhanced delivery; degradomer; drug delivery; exosomes; focused ultrasound; intracerebroventricular delivery; nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha